CDK14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.396000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.408000E-02
Normal-vs-Stage2
6.362800E-01
Normal-vs-Stage3
1.536800E-01
Normal-vs-Stage4
8.260400E-01
Stage1-vs-Stage2
2.624400E-01
Stage1-vs-Stage3
6.073600E-01
Stage1-vs-Stage4
1.045020E-01
Stage2-vs-Stage3
5.815800E-01
Stage2-vs-Stage4
4.174400E-01
Stage3-vs-Stage4
2.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.396400E-01
Normal-vs-AfricanAmerican
8.890000E-01
Normal-vs-Asian
3.889700E-02
Caucasian-vs-AfricanAmerican
6.024600E-01
Caucasian-vs-Asian
1.377770E-02
AfricanAmerican-vs-Asian
2.447500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.686000E-01
Normal-vs-Female
5.974400E-01
Male-vs-Female
7.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.788400E-01
Normal-vs-Age(41-60Yrs)
9.814800E-01
Normal-vs-Age(61-80Yrs)
4.815600E-01
Normal-vs-Age(81-100Yrs)
5.382000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.079000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.359600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.550600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.823700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.132200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.716000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.394200E-01
Normal-vs-Daily Drinker
7.196300E-02
Normal-vs-Weekly Drinker
1.587980E-01
Normal-vs-Occasional Drinker
8.177600E-01
Normal-vs-Social Drinker
9.800400E-01
Non Drinker-vs-Daily Drinker
4.747400E-01
Non Drinker-vs-Weekly Drinker
8.633600E-01
Non Drinker-vs-Occasional Drinker
1.301630E-01
Non Drinker-vs-Social Drinker
2.290200E-01
Daily Drinker-vs-Weekly Drinker
6.355600E-01
Daily Drinker-vs-Occasional Drinker
7.830400E-02
Daily Drinker-vs-Social Drinker
1.349050E-01
Weekly Drinker-vs-Occasional Drinker
1.184570E-01
Weekly Drinker-vs-Social Drinker
2.074000E-01
Occasional Drinker-vs-Social Drinker
6.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.725600E-01
Normal-vs-Grade 2
3.083200E-01
Normal-vs-Grade 3
3.766200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.530200E-01
Grade 1-vs-Grade 3
1.264800E-01
Grade 1-vs-Grade 4
4.725600E-01
Grade 2-vs-Grade 3
3.093600E-01
Grade 2-vs-Grade 4
3.083200E-01
Grade 3-vs-Grade 4
3.766200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.993400E-01
Normal-vs-NonDiabetic
6.469200E-01
Diabetic-vs-NonDiabetic
8.176800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.635700E-02
Normal-vs-NoPancreatitis
7.019800E-01
Pancreatitis-vs-NoPancreatitis
1.039410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.602800E-01
Normal-vs-N1
6.596200E-01
N0-vs-N1
6.426400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.469800E-01
Normal-vs-TP53-NonMutant
5.637600E-01
TP53-Mutant-vs-TP53-NonMutant
2.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
